Neuroendocrine Differentiated (NED) Prostate Cancer
1 clinical trials · Condition
◉ Watch Neuroendocrine Differentiated (NED) Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours (NCT05605522) | 3B Pharmaceuticals GmbH | 2023-02-07 |
Track Neuroendocrine Differentiated (NED) Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.